Literature DB >> 17200708

Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.

Robert J Coffey1, Mary Kay Washington, Christopher L Corless, Michael C Heinrich.   

Abstract

Ménétrier disease and gastrointestinal stromal tumors (GISTs) are hyperproliferative disorders of the stomach caused by dysregulated receptor tyrosine kinases (RTKs). In Ménétrier disease, overexpression of TGF-alpha, a ligand for the RTK EGFR, results in selective expansion of surface mucous cells in the body and fundus of the stomach. In GISTs, somatic mutations of the genes encoding the RTK KIT (or PDGFRA in a minority of cases) result in constitutive kinase activity and neoplastic transformation of gut pacemaker cells (interstitial cells of Cajal). On the basis of the involvement of these RTKs in the pathogenesis of these disorders, Ménétrier disease patients have been effectively treated with a blocking monoclonal antibody specific for EGFR and GIST patients with KIT and PDGFRA tyrosine kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200708      PMCID: PMC1716220          DOI: 10.1172/JCI30491

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  105 in total

1.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.

Authors:  George D Demetri; Allan T van Oosterom; Christopher R Garrett; Martin E Blackstein; Manisha H Shah; Jaap Verweij; Grant McArthur; Ian R Judson; Michael C Heinrich; Jeffrey A Morgan; Jayesh Desai; Christopher D Fletcher; Suzanne George; Carlo L Bello; Xin Huang; Charles M Baum; Paolo G Casali
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

Review 2.  ErbB receptors: new insights on mechanisms and biology.

Authors:  Bryan Linggi; Graham Carpenter
Journal:  Trends Cell Biol       Date:  2006-11-07       Impact factor: 20.808

3.  Production and auto-induction of transforming growth factor-alpha in human keratinocytes.

Authors:  R J Coffey; R Derynck; J N Wilcox; T S Bringman; A S Goustin; H L Moses; M R Pittelkow
Journal:  Nature       Date:  1987 Aug 27-Sep 2       Impact factor: 49.962

4.  Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism.

Authors:  J J Lewis; J R Goldenring; I M Modlin; R J Coffey
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

5.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

6.  Intramucosal carcinoma of the gastric antrum complicating Menetrier's disease.

Authors:  M G Wood; C Bates; R C Brown; M S Losowsky
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

7.  Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.

Authors:  Maria Debiec-Rychter; Bartosz Wasag; Michel Stul; Ivo De Wever; Allan Van Oosterom; Anne Hagemeijer; Raf Sciot
Journal:  J Pathol       Date:  2004-04       Impact factor: 7.996

8.  Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal.

Authors:  R D Beauchamp; J A Barnard; C M McCutchen; J A Cherner; R J Coffey
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

9.  Myosarcomas of the stomach: natural history, prognostic factors and management.

Authors:  M H Shiu; G H Farr; D N Papachristou; S I Hajdu
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

Review 10.  NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

Authors:  George D Demetri; Robert S Benjamin; Charles D Blanke; Jean-Yves Blay; Paolo Casali; Haesun Choi; Christopher L Corless; Maria Debiec-Rychter; Ronald P DeMatteo; David S Ettinger; George A Fisher; Christopher D M Fletcher; Alessandro Gronchi; Peter Hohenberger; Miranda Hughes; Heikki Joensuu; Ian Judson; Axel Le Cesne; Robert G Maki; Michael Morse; Alberto S Pappo; Peter W T Pisters; Chandrajit P Raut; Peter Reichardt; Douglas S Tyler; Annick D Van den Abbeele; Margaret von Mehren; Jeffrey D Wayne; John Zalcberg
Journal:  J Natl Compr Canc Netw       Date:  2007-07       Impact factor: 11.908

View more
  37 in total

1.  Distinguishing Ménétrier's disease from its mimics.

Authors:  Amy Rich; Tania Zuluaga Toro; Jarred Tanksley; William H Fiske; Christopher D Lind; Gregory D Ayers; Hubert Piessevaux; Mary K Washington; Robert J Coffey
Journal:  Gut       Date:  2010-10-06       Impact factor: 23.059

Review 2.  Ménétrier's disease of the stomach: a clinical challenge.

Authors:  Nils W G Lambrecht
Journal:  Curr Gastroenterol Rep       Date:  2011-12

Review 3.  Beyond gastritis and before cancer: the strange case of Ménétrier's disease.

Authors:  Giuseppe Famularo; Maria Rosaria Sajeva; Laura Gasbarrone
Journal:  Intern Emerg Med       Date:  2010-10-14       Impact factor: 3.397

Review 4.  Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease.

Authors:  Juanita L Merchant
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

6.  Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.

Authors:  Michael Rothenberg; Reetesh Pai; Kevin Stuart
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

7.  Early gastric cancer in Menetrier's disease.

Authors:  Jose Maria Remes-Troche; Juan Carlos Zapata-Colindres; Ivethe Starkman; Jazmin De Anda; Julian Arista-Nasr; Miguel Angel Valdovinos-Diaz
Journal:  BMJ Case Rep       Date:  2009-03-26

8.  Generation of stomach tissue from mouse embryonic stem cells.

Authors:  Taka-aki K Noguchi; Naoto Ninomiya; Mari Sekine; Shinji Komazaki; Pi-Chao Wang; Makoto Asashima; Akira Kurisaki
Journal:  Nat Cell Biol       Date:  2015-07-20       Impact factor: 28.824

9.  The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.

Authors:  Shradha S Khurana; Terrence E Riehl; Benjamin D Moore; Matteo Fassan; Massimo Rugge; Judith Romero-Gallo; Jennifer Noto; Richard M Peek; William F Stenson; Jason C Mills
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

10.  The Association of Ménétrier Disease with Ulcerative Colitis: A Case Report with Implications on the Pathogenesis of Ménétrier Disease.

Authors:  Vien X Nguyen; Cuong C Nguyen; Jonathan A Leighton; Shabana F Pasha; Alvin C Silva; Jacques P Heppell; Giovanni De Petris
Journal:  Case Rep Gastroenterol       Date:  2010-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.